Objectives: 

1. Understand agreement of PD-L1 assays in lung cancer

2. Identify components of effective antitumor immune response

3. Identify emerging biomarkers for immunotherapy

Session date: 
11/30/2017 - 8:00am to 9:00am CST
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Aaron S. Mansfield, M.D.